首页/数据集/Supplementary Tables from TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

Supplementary Tables from TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors

NIAID Data Ecosystem2026-05-10 收录

数据链接：

https://figshare.com/articles/dataset/Supplementary_Tables_from_TRK_xDFG_Mutations_Trigger_a_Sensitivity_Switch_from_Type_I_to_II_Kinase_Inhibitors/22536727 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Tables

应用场景：

创建时间：

2021-01-01

肿瘤靶向治疗

药物耐药机制

Protein arginine methyltransferase 5 (PRMT5) over-expression in hematological and solid tumors methylates arginine residues on cellular proteins involved in important cancer functions including cell c

NIAID Data Ecosystem90

Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysis

NTRK融合肿瘤

肿瘤靶向治疗

NTRK gene fusions have been identified in various tumors; some requiring aggressive therapy and sometimes new TRK inhibitors (TRKi). We aimed to describe a national, unselected, retrospective, multice

Figshare2023-08-01 更新10

Supplementary Table S2 from Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors

MET外显子14突变

肿瘤靶向治疗

Summary of MET exon 14 alterations.

NIAID Data Ecosystem10

肿瘤靶分子临床研究信息数据集

肿瘤靶向治疗

临床研究

聚焦肿瘤靶分子临床研究全流程，整合靶点发现、临床试验设计、疗效数据、安全性评估等核心信息。数据经标准化清洗与专业校验，关联靶点分子结构、作用机制及临床结果，支持科研机构靶点验证、药企药物研发、临床机构方案优化，为靶分子临床转化提供高质量、可溯源的数据支撑。

江苏数据交易所80

The influence of TKI therapy on EGFR mutations status.